SCHEMBL4851385

SCHEMBL4851385

COc1ccc(C(=O)C=Cc2cccc(OCCN(C)C)c2)c(F)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.59
ABCG2 Q9UNQ0 4/20 0.57
MEN1 O00255 3/20 0.55
LMNA P02545 3/20 0.55
KMT2A Q03164 3/20 0.55
HPGD P15428 2/20 0.55
ALDH1A1 P00352 1/20 0.54
GAA P10253 1/20 0.54
ALOX12 P18054 1/20 0.54
NR1H4 Q96RI1 3/20 0.54
BCHE P06276 3/20 0.53
ACHE P22303 2/20 0.53
MAOB P27338 2/20 0.52
MAOA P21397 1/20 0.52
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
NPC1 O15118 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849937 0.95 APP (0.58) APPABCG2MEN1LMNAKMT2A
SCHEMBL4854115 0.89 MAPT (0.63) APPABCG2MEN1KMT2ANR1H4
SCHEMBL4851228 0.87 ABCG2 (0.60) APPABCG2NR1H4BCHEACHE
SCHEMBL4845309 0.87 ABCG2 (0.60) APPABCG2NR1H4BCHEACHE
SCHEMBL4846088 0.84 MAOB (0.71) APPMEN1KMT2AALDH1A1BCHE
SCHEMBL4853023 0.84 MAPT (0.61) APPABCG2MEN1KMT2ANR1H4
SCHEMBL4849956 0.82 LMNA (0.53) ABCG2MEN1LMNAKMT2AHPGD
SCHEMBL5915496 0.82 MEN1 (0.58) APPABCG2MEN1LMNAKMT2A
SCHEMBL4848357 0.82 MAOB (0.60) APPABCG2NR1H4BCHEACHE
SCHEMBL4852954 0.82 ABCG2 (0.59) APPABCG2NR1H4BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed